The Patent Finder

ADC Therapeutics S.A.

Also on record
Records under this name other than the patents ADC Therapeutics S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 11 patents it holds.

Back to ADC Therapeutics S.A.

PatentTitleStatus Expires Confidence
US 10,736,903Pyrrolobenzodiazepine-Anti-Psma Antibody Conjugates
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,780,181Pyrrolobenzodiazepine-Antibody Conjugates
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,799,596Pyrrolobenzodiazepine-Antibody Conjugates
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,771,775Pyrrolobenzodiazepine-Antibody Conjugates
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,779,650Pyrrolobenzodiazepine-Antibody Conjugates
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 9,950,078Pyrrolobenzodiazepine-Antibody Conjugates
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 9,931,414Pyrrolobenzodiazepine-Antibody Conjugates
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,059,893Humanized anti-AXL antibodies
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,544,223Combination Therapy with an Anti-Axl Antibody-Drug Conjugate
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,813,335Pyrrolobenzodiazepine-Antibody Conjugates
Formerly held
In force
 · High confidence
In forceHigh confidence
10 of 27 patents shown.
Pro members see all 27.
Pro members: see all 27 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited